Kairos Pharma, Ltd. ( KAPA) - Key Metrics
KAPA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.06 | -$0.05 | -$0.05 |
| 2026Q1 | $0 | -$0.08 | -$0.05 | -$0.05 |
| 2025Q4 | $0 | -$0.07 | -$0.06 | -$0.06 |
| 2025Q3 | $0 | -$0.07 | -$0.04 | -$0.04 |
| 2025Q2 | $0 | -$0.08 | -$0.05 | -$0.05 |
KAPA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.60 |
| 2026Q1 | 0% | -1.78 |
| 2025Q4 | 0% | -2.61 |
| 2025Q3 | 0% | -4.18 |
| 2025Q2 | 0% | -2.15 |
KAPA
Price: $0.60
52 week price:
Earnings Per Share: -0.27 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 4.8 million